Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Endovascular AAA Graft System Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Endovascular AAA Graft System Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 139 Pages
Report ld: 6301426
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Endovascular AAA Graft System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The endovascular AAA (abdominal aortic aneurysm) graft system is a medical device used to treat abdominal aortic diseases. It's a long, tubular support structure made of metal or polymeric materials. It's placed in the diseased part of the abdominal aorta through an interventional procedure to support the vessel wall and keep the blood vessel patent. It's mainly used to treat severe vascular diseases such as abdominal aortic aneurysm and abdominal aortic dissection.
From a downstream perspective, Hospital accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Endovascular AAA Graft System leading manufacturers (including Medtronic, Gore, Endologix, Cordis, Terumo, Cook, Xinmai Medical, Lifetech Scientific, Beijing Huaimai Taike, etc.), dominate supply; the top five capture approximately % of global revenue, with Medtronic leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Endovascular AAA Graft System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Medtronic
- Gore
- Endologix
- Cordis
- Terumo
- Cook
- Xinmai Medical
- Lifetech Scientific
- Beijing Huaimai Taike
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- <14Fr
- 14-18Fr
- 18-22Fr
- >22Fr
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Endovascular AAA Graft System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Endovascular AAA Graft System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Endovascular AAA Graft System Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 <14Fr
1.2.3 14-18Fr
1.2.4 18-22Fr
1.2.5 >22Fr
1.3 Market Segmentation by Application
1.3.1 Global Endovascular AAA Graft System Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Endovascular AAA Graft System Revenue Estimates and Forecasts (2021-2032)
2.2 Global Endovascular AAA Graft System Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Endovascular AAA Graft System Sales Estimates and Forecasts (2021-2032)
2.4 Global Endovascular AAA Graft System Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Endovascular AAA Graft System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Endovascular AAA Graft System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 <14Fr: Market Share by Key Manufacturers
3.5.2 14-18Fr: Market Share by Key Manufacturers
3.5.3 18-22Fr: Market Share by Key Manufacturers
3.5.4 >22Fr: Market Share by Key Manufacturers
3.6 Global Endovascular AAA Graft System Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Endovascular AAA Graft System Sales Performance by Type
4.1.1 Global Endovascular AAA Graft System Sales Volume by Type (2021-2032)
4.1.2 Global Endovascular AAA Graft System Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Endovascular AAA Graft System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Endovascular AAA Graft System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Endovascular AAA Graft System Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Endovascular AAA Graft System Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Endovascular AAA Graft System Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Endovascular AAA Graft System Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Endovascular AAA Graft System Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Endovascular AAA Graft System Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Endovascular AAA Graft System Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Endovascular AAA Graft System Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Endovascular AAA Graft System Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Endovascular AAA Graft System Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.1.4 Medtronic Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Medtronic Endovascular AAA Graft System Sales by Product in 2025
11.1.6 Medtronic Endovascular AAA Graft System Sales by Application in 2025
11.1.7 Medtronic Endovascular AAA Graft System Sales by Geographic Area in 2025
11.1.8 Medtronic Endovascular AAA Graft System SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Gore
11.2.1 Gore Corporation Information
11.2.2 Gore Business Overview
11.2.3 Gore Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.2.4 Gore Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Gore Endovascular AAA Graft System Sales by Product in 2025
11.2.6 Gore Endovascular AAA Graft System Sales by Application in 2025
11.2.7 Gore Endovascular AAA Graft System Sales by Geographic Area in 2025
11.2.8 Gore Endovascular AAA Graft System SWOT Analysis
11.2.9 Gore Recent Developments
11.3 Endologix
11.3.1 Endologix Corporation Information
11.3.2 Endologix Business Overview
11.3.3 Endologix Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.3.4 Endologix Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Endologix Endovascular AAA Graft System Sales by Product in 2025
11.3.6 Endologix Endovascular AAA Graft System Sales by Application in 2025
11.3.7 Endologix Endovascular AAA Graft System Sales by Geographic Area in 2025
11.3.8 Endologix Endovascular AAA Graft System SWOT Analysis
11.3.9 Endologix Recent Developments
11.4 Cordis
11.4.1 Cordis Corporation Information
11.4.2 Cordis Business Overview
11.4.3 Cordis Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.4.4 Cordis Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Cordis Endovascular AAA Graft System Sales by Product in 2025
11.4.6 Cordis Endovascular AAA Graft System Sales by Application in 2025
11.4.7 Cordis Endovascular AAA Graft System Sales by Geographic Area in 2025
11.4.8 Cordis Endovascular AAA Graft System SWOT Analysis
11.4.9 Cordis Recent Developments
11.5 Terumo
11.5.1 Terumo Corporation Information
11.5.2 Terumo Business Overview
11.5.3 Terumo Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.5.4 Terumo Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Terumo Endovascular AAA Graft System Sales by Product in 2025
11.5.6 Terumo Endovascular AAA Graft System Sales by Application in 2025
11.5.7 Terumo Endovascular AAA Graft System Sales by Geographic Area in 2025
11.5.8 Terumo Endovascular AAA Graft System SWOT Analysis
11.5.9 Terumo Recent Developments
11.6 Cook
11.6.1 Cook Corporation Information
11.6.2 Cook Business Overview
11.6.3 Cook Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.6.4 Cook Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Cook Recent Developments
11.7 Xinmai Medical
11.7.1 Xinmai Medical Corporation Information
11.7.2 Xinmai Medical Business Overview
11.7.3 Xinmai Medical Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.7.4 Xinmai Medical Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Xinmai Medical Recent Developments
11.8 Lifetech Scientific
11.8.1 Lifetech Scientific Corporation Information
11.8.2 Lifetech Scientific Business Overview
11.8.3 Lifetech Scientific Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.8.4 Lifetech Scientific Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Lifetech Scientific Recent Developments
11.9 Beijing Huaimai Taike
11.9.1 Beijing Huaimai Taike Corporation Information
11.9.2 Beijing Huaimai Taike Business Overview
11.9.3 Beijing Huaimai Taike Endovascular AAA Graft System Product Models, Descriptions and Specifications
11.9.4 Beijing Huaimai Taike Endovascular AAA Graft System Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 Beijing Huaimai Taike Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Endovascular AAA Graft System Industry Chain
12.2 Endovascular AAA Graft System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Endovascular AAA Graft System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Endovascular AAA Graft System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Endovascular AAA Graft System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Endovascular AAA Graft System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Endovascular AAA Graft System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Endovascular AAA Graft System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Endovascular AAA Graft System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Endovascular AAA Graft System Revenue by Region (US$ Million), 2021-2026
Table 5. Global Endovascular AAA Graft System Revenue by Region (US$ Million), 2027-2032
Table 6. Global Endovascular AAA Graft System Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 7. Global Endovascular AAA Graft System Sales by Region (K Units), 2021-2026
Table 8. Global Endovascular AAA Graft System Sales by Region (K Units), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global Endovascular AAA Graft System Sales by Manufacturers (K Units), 2021-2026
Table 11. Global Endovascular AAA Graft System Sales Share by Manufacturers (2021-2026)
Table 12. Global Endovascular AAA Graft System Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global Endovascular AAA Graft System Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Endovascular AAA Graft System Revenue, 2025
Table 16. Global Endovascular AAA Graft System Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global Endovascular AAA Graft System Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 18. Key Manufacturers Endovascular AAA Graft System Manufacturing Base and Headquarters
Table 19. Global Endovascular AAA Graft System Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Endovascular AAA Graft System Sales Volume by Type (K Units), 2021-2026
Table 23. Global Endovascular AAA Graft System Sales Volume by Type (K Units), 2027-2032
Table 24. Global Endovascular AAA Graft System Revenue by Type (US$ Million), 2021-2026
Table 25. Global Endovascular AAA Graft System Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global Endovascular AAA Graft System Sales by Application (K Units), 2021-2026
Table 28. Global Endovascular AAA Graft System Sales by Application (K Units), 2027-2032
Table 29. Endovascular AAA Graft System High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global Endovascular AAA Graft System Revenue by Application (US$ Million), 2021-2026
Table 31. Global Endovascular AAA Graft System Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America Endovascular AAA Graft System Growth Accelerators and Market Barriers
Table 35. North America Endovascular AAA Graft System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America Endovascular AAA Graft System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 37. Europe Endovascular AAA Graft System Growth Accelerators and Market Barriers
Table 38. Europe Endovascular AAA Graft System Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe Endovascular AAA Graft System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific Endovascular AAA Graft System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific Endovascular AAA Graft System Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific Endovascular AAA Graft System Growth Accelerators and Market Barriers
Table 43. Southeast Asia Endovascular AAA Graft System Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America Endovascular AAA Graft System Investment Opportunities and Key Challenges
Table 45. Central and South America Endovascular AAA Graft System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa Endovascular AAA Graft System Investment Opportunities and Key Challenges
Table 47. Middle East and Africa Endovascular AAA Graft System Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. Medtronic Corporation Information
Table 49. Medtronic Description and Major Businesses
Table 50. Medtronic Product Models, Descriptions and Specifications
Table 51. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 52. Medtronic Sales Value Proportion by Product in 2025
Table 53. Medtronic Sales Value Proportion by Application in 2025
Table 54. Medtronic Sales Value Proportion by Geographic Area in 2025
Table 55. Medtronic Endovascular AAA Graft System SWOT Analysis
Table 56. Medtronic Recent Developments
Table 57. Gore Corporation Information
Table 58. Gore Description and Major Businesses
Table 59. Gore Product Models, Descriptions and Specifications
Table 60. Gore Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Gore Sales Value Proportion by Product in 2025
Table 62. Gore Sales Value Proportion by Application in 2025
Table 63. Gore Sales Value Proportion by Geographic Area in 2025
Table 64. Gore Endovascular AAA Graft System SWOT Analysis
Table 65. Gore Recent Developments
Table 66. Endologix Corporation Information
Table 67. Endologix Description and Major Businesses
Table 68. Endologix Product Models, Descriptions and Specifications
Table 69. Endologix Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 70. Endologix Sales Value Proportion by Product in 2025
Table 71. Endologix Sales Value Proportion by Application in 2025
Table 72. Endologix Sales Value Proportion by Geographic Area in 2025
Table 73. Endologix Endovascular AAA Graft System SWOT Analysis
Table 74. Endologix Recent Developments
Table 75. Cordis Corporation Information
Table 76. Cordis Description and Major Businesses
Table 77. Cordis Product Models, Descriptions and Specifications
Table 78. Cordis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Cordis Sales Value Proportion by Product in 2025
Table 80. Cordis Sales Value Proportion by Application in 2025
Table 81. Cordis Sales Value Proportion by Geographic Area in 2025
Table 82. Cordis Endovascular AAA Graft System SWOT Analysis
Table 83. Cordis Recent Developments
Table 84. Terumo Corporation Information
Table 85. Terumo Description and Major Businesses
Table 86. Terumo Product Models, Descriptions and Specifications
Table 87. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Terumo Sales Value Proportion by Product in 2025
Table 89. Terumo Sales Value Proportion by Application in 2025
Table 90. Terumo Sales Value Proportion by Geographic Area in 2025
Table 91. Terumo Endovascular AAA Graft System SWOT Analysis
Table 92. Terumo Recent Developments
Table 93. Cook Corporation Information
Table 94. Cook Description and Major Businesses
Table 95. Cook Product Models, Descriptions and Specifications
Table 96. Cook Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cook Recent Developments
Table 98. Xinmai Medical Corporation Information
Table 99. Xinmai Medical Description and Major Businesses
Table 100. Xinmai Medical Product Models, Descriptions and Specifications
Table 101. Xinmai Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Xinmai Medical Recent Developments
Table 103. Lifetech Scientific Corporation Information
Table 104. Lifetech Scientific Description and Major Businesses
Table 105. Lifetech Scientific Product Models, Descriptions and Specifications
Table 106. Lifetech Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Lifetech Scientific Recent Developments
Table 108. Beijing Huaimai Taike Corporation Information
Table 109. Beijing Huaimai Taike Description and Major Businesses
Table 110. Beijing Huaimai Taike Product Models, Descriptions and Specifications
Table 111. Beijing Huaimai Taike Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Beijing Huaimai Taike Recent Developments
Table 113. Key Raw Materials Distribution
Table 114. Raw Materials Key Suppliers
Table 115. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 116. Milestones in Production Technology Evolution
Table 117. Distributors List
Table 118. Market Trends and Market Evolution
Table 119. Market Drivers and Opportunities
Table 120. Market Challenges, Risks, and Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Endovascular AAA Graft System Product Picture
Figure 2. Global Endovascular AAA Graft System Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. <14Fr Product Picture
Figure 4. 14-18Fr Product Picture
Figure 5. 18-22Fr Product Picture
Figure 6. >22Fr Product Picture
Figure 7. Global Endovascular AAA Graft System Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Endovascular AAA Graft System Report Years Considered
Figure 12. Global Endovascular AAA Graft System Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 14. Global Endovascular AAA Graft System Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 15. Global Endovascular AAA Graft System Revenue-Based Market Share by Region (2021-2032)
Figure 16. Global Endovascular AAA Graft System Sales (K Units), 2021-2032
Figure 17. Global Endovascular AAA Graft System Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 18. Global Endovascular AAA Graft System Sales Market Share by Region (2021-2032)
Figure 19. Top 5 and Top 10 Manufacturers Endovascular AAA Graft System Sales Volume Market Share in 2025
Figure 20. Global Endovascular AAA Graft System Revenue-Based Market Share Ranking (2025)
Figure 21. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 22. <14Fr Revenue-Based Market Share by Manufacturer in 2025
Figure 23. 14-18Fr Revenue-Based Market Share by Manufacturer in 2025
Figure 24. 18-22Fr Revenue-Based Market Share by Manufacturer in 2025
Figure 25. >22Fr Revenue-Based Market Share by Manufacturer in 2025
Figure 26. Global Endovascular AAA Graft System Sales Volume-Based Market Share by Type (2021-2032)
Figure 27. Global Endovascular AAA Graft System Revenue-Based Market Share by Type (2021-2032)
Figure 28. Global Endovascular AAA Graft System ASP by Type (US$/Unit), 2021-2032
Figure 29. Global Endovascular AAA Graft System Revenue-Based Market Share (2021-2032)
Figure 30. Global Endovascular AAA Graft System Sales Market Share by Application (2021-2032)
Figure 31. Global Endovascular AAA Graft System Revenue-Based Market Share by Application (2021-2032)
Figure 32. Global Endovascular AAA Graft System ASP by Application (US$/Unit), 2021-2032
Figure 33. North America Endovascular AAA Graft System Sales YoY (K Units), 2021-2032
Figure 34. North America Endovascular AAA Graft System Revenue YoY (US$ Million), 2021-2032
Figure 35. North America Top 5 Manufacturers Endovascular AAA Graft System Sales Revenue (US$ Million) in 2025
Figure 36. North America Endovascular AAA Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 37. North America Endovascular AAA Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 38. US Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 39. Canada Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 40. Mexico Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 41. Europe Endovascular AAA Graft System Sales YoY (K Units), 2021-2032
Figure 42. Europe Endovascular AAA Graft System Revenue YoY (US$ Million), 2021-2032
Figure 43. Europe Top 5 Manufacturers Endovascular AAA Graft System Sales Revenue (US$ Million) in 2025
Figure 44. Europe Endovascular AAA Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 45. Europe Endovascular AAA Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 46. Germany Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 47. France Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 48. U.K. Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 49. Italy Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 50. Russia Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 51. Asia-Pacific Endovascular AAA Graft System Sales YoY (K Units), 2021-2032
Figure 52. Asia-Pacific Endovascular AAA Graft System Revenue YoY (US$ Million), 2021-2032
Figure 53. Asia-Pacific Top 8 Manufacturers Endovascular AAA Graft System Sales Revenue (US$ Million) in 2025
Figure 54. Asia-Pacific Endovascular AAA Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 55. Asia-Pacific Endovascular AAA Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 56. Indonesia Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 57. Japan Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 58. South Korea Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 59. China Taiwan Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 60. India Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 61. Central and South America Endovascular AAA Graft System Sales YoY (K Units), 2021-2032
Figure 62. Central and South America Endovascular AAA Graft System Revenue YoY (US$ Million), 2021-2032
Figure 63. Central and South America Top 5 Manufacturers Endovascular AAA Graft System Sales Revenue (US$ Million) in 2025
Figure 64. Central and South America Endovascular AAA Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 65. Central and South America Endovascular AAA Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 66. Brazil Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 67. Argentina Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 68. Middle East, and Africa Endovascular AAA Graft System Sales YoY (K Units), 2021-2032
Figure 69. Middle East and Africa Endovascular AAA Graft System Revenue YoY (US$ Million), 2021-2032
Figure 70. Middle East and Africa Top 5 Manufacturers Endovascular AAA Graft System Sales Revenue (US$ Million) in 2025
Figure 71. Middle East and Africa Endovascular AAA Graft System Sales Volume (K Units) by Application (2021-2032)
Figure 72. Middle East and Africa Endovascular AAA Graft System Sales Revenue (US$ Million) by Application (2021-2032)
Figure 73. GCC Countries Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 74. Turkey Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 75. Egypt Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 76. South Africa Endovascular AAA Graft System Revenue (US$ Million), 2021-2032
Figure 77. Endovascular AAA Graft System Industry Chain Mapping
Figure 78. Regional Endovascular AAA Graft System Manufacturing Base Distribution (%)
Figure 79. Global Endovascular AAA Graft System Production Market Share by Region (2021-2032)
Figure 80. Endovascular AAA Graft System Production Process
Figure 81. Regional Endovascular AAA Graft System Production Cost Structure
Figure 82. Channels of Distribution (Direct Vs Distribution)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Endovascular AAA Graft System market?
The top companies in the global Endovascular AAA Graft System market are Medtronic、Gore、Endologix.
Related Reports
Global Endovascular AAA Graft System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Endovascular AAA Graft System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 76
USD 4250.00
(Single User License)
Endovascular AAA Graft System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Endovascular AAA Graft System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 101
USD 3950.00
(Single User License)
Global Endovascular AAA Graft System Market Research Report 2026
The global Endovascular AAA Graft System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 110
USD 2900.00
(Single User License)
Global Endovascular AAA Graft System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Endovascular AAA Graft System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
Global Endovascular AAA Graft System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Endovascular AAA Graft System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 76
USD 4250.00
(Single User License)
Endovascular AAA Graft System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Endovascular AAA Graft System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 93
USD 3950.00
(Single User License)
Global Endovascular AAA Graft System Market Research Report 2025
The global market for Endovascular AAA Graft System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 80
USD 2900.00
(Single User License)
Global and United States Endovascular AAA Graft System Market Report & Forecast 2024-2030
The endovascular AAA (abdominal aortic aneurysm) graft system is a medical device used to treat abdominal aortic diseases. It's a long, tubular support structure made of metal or polymeric materials. It's placed in the diseased part of the abdominal aorta through an interventional procedure to support the vessel wall and keep the blood vessel patent. It's mainly used to treat severe vascular diseases such as abdominal aortic aneurysm and abdominal aortic dissection.
Published Date: 2024-10-27
Pages: 102
USD 4350.00
(Single User License)
Global Endovascular AAA Graft System Market Research Report 2024
The endovascular AAA (abdominal aortic aneurysm) graft system is a medical device used to treat abdominal aortic diseases. It's a long, tubular support structure made of metal or polymeric materials. It's placed in the diseased part of the abdominal aorta through an interventional procedure to support the vessel wall and keep the blood vessel patent. It's mainly used to treat severe vascular diseases such as abdominal aortic aneurysm and abdominal aortic dissection.
Published Date: 2024-10-27
Pages: 82
USD 2900.00
(Single User License)
Global Endovascular AAA Graft System Market Insights, Forecast to 2030
The endovascular AAA (abdominal aortic aneurysm) graft system is a medical device used to treat abdominal aortic diseases. It's a long, tubular support structure made of metal or polymeric materials. It's placed in the diseased part of the abdominal aorta through an interventional procedure to support the vessel wall and keep the blood vessel patent. It's mainly used to treat severe vascular diseases such as abdominal aortic aneurysm and abdominal aortic dissection.
Published Date: 2024-10-27
Pages: 139
USD 4900.00
(Single User License)
Global Endovascular AAA Graft System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Endovascular AAA Graft System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 76
USD 4250.00 (Single User License)Endovascular AAA Graft System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Endovascular AAA Graft System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 101
USD 3950.00 (Single User License)Global Endovascular AAA Graft System Market Research Report 2026
The global Endovascular AAA Graft System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 110
USD 2900.00 (Single User License)Global Endovascular AAA Graft System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Endovascular AAA Graft System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
USD 4900.00 (Single User License)Global Endovascular AAA Graft System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Endovascular AAA Graft System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 76
USD 4250.00 (Single User License)Endovascular AAA Graft System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Endovascular AAA Graft System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 93
USD 3950.00 (Single User License)Global Endovascular AAA Graft System Market Research Report 2025
The global market for Endovascular AAA Graft System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 80
USD 2900.00 (Single User License)Global and United States Endovascular AAA Graft System Market Report & Forecast 2024-2030
The endovascular AAA (abdominal aortic aneurysm) graft system is a medical device used to treat abdominal aortic diseases. It's a long, tubular support structure made of metal or polymeric materials. It's placed in the diseased part of the abdominal aorta through an interventional procedure to support the vessel wall and keep the blood vessel patent. It's mainly used to treat severe vascular diseases such as abdominal aortic aneurysm and abdominal aortic dissection.
Published: 2024-10-27
Pages: 102
USD 4350.00 (Single User License)Global Endovascular AAA Graft System Market Research Report 2024
The endovascular AAA (abdominal aortic aneurysm) graft system is a medical device used to treat abdominal aortic diseases. It's a long, tubular support structure made of metal or polymeric materials. It's placed in the diseased part of the abdominal aorta through an interventional procedure to support the vessel wall and keep the blood vessel patent. It's mainly used to treat severe vascular diseases such as abdominal aortic aneurysm and abdominal aortic dissection.
Published: 2024-10-27
Pages: 82
USD 2900.00 (Single User License)Global Endovascular AAA Graft System Market Insights, Forecast to 2030
The endovascular AAA (abdominal aortic aneurysm) graft system is a medical device used to treat abdominal aortic diseases. It's a long, tubular support structure made of metal or polymeric materials. It's placed in the diseased part of the abdominal aorta through an interventional procedure to support the vessel wall and keep the blood vessel patent. It's mainly used to treat severe vascular diseases such as abdominal aortic aneurysm and abdominal aortic dissection.
Published: 2024-10-27
Pages: 139
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now